Amyloid-beta 40

There are 216 papers on amyloid-beta 40 in aging research: 20 trials and 153 observational studies in people, 25 in animals, 12 reviews. The newest story, Nov 17, 2026: “Aging linked to blood and brain changes in chimpanzees”.

Biomarker

216 papers study it1 more mentions it39 findings

7 new papers in 30 daysSee all 217 papers on amyloid-beta 40

“Being never married was associated with higher plasma amyloid-β40”
Sex-differences in the association of social health and marital status with blood-based immune and neurodegeneration markers in a cohort of community-dwelling older adultsBrain, behavior, and immunity2024doi:10.1016/j.bbi.2024.05.031
  • Human trial20
  • Humans153
  • Animals25
  • In silico2

Interventions

11

Dual-task functional power training

upin humans1+11% net decrease

1 study
  1. Dual-task functional power training improves amyloid-beta 40 in humans (10.5% net decrease).

    “For Aβ (1–40), there was a mean 10.5% significant net benefit (decrease) for the change in DT-FPT compared to CON (group-by-time interaction, P = 0.032), due to no change in DT-FPT (-2.7%, P = 0.200) and a 7.8% (P = 0.006) increase in CON.”

    Human trial6 monthsn = 300

    Effects of a 6-month dual-task, power-based exercise program on cognitive function, neurological and inflammatory markers in older adults: secondary analysis of a cluster randomised controlled trial

    GeroScience

  2. Dual-task functional power training improves amyloid-beta 40 in humans (at increased falls risk) (net 10.5% benefit).

    “There were no significant intervention effects on circulating markers, except for a net 10.5% benefit in amyloid β (1-40) in DT-FPT versus CON (P < 0.05).”

    Human trialat increased falls risk6-monthn = 233

    Effects of a 6-month dual-task, power-based exercise program on cognitive function, neurological and inflammatory markers in older adults: secondary analysis of a cluster randomised controlled trial

    GeroScience

More on Dual-task functional power training

Cinaciguat

downin rats1

1 study
  1. Cinaciguat decreases amyloid-beta 40 in rats (halved).

    “in aged rats, two weeks of the soluble guanylate cyclase activator cinaciguat restored fenestration; circulating amyloid-beta 40 levels halved”

    Animalstwo weeks

    Activating soluble guanylate cyclase restores amyloid-beta and LDL clearance in aged rats

    The Journal of biological chemistry

More on Cinaciguat

Physical activity

downin humans1

1 study
  1. Physical activity is linked with lower amyloid-beta 40 in humans.

    “lower amyloid beta 40, total tau, and larger hippocampal subregion volumes in females (ps < 0.05)”

    Humansfemales

    Role of sex and ethnicity in the relationships among physical activity, cognition, and AD biomarkers in the HABS-HD cohort

    Alzheimer's & dementia (Amsterdam, Netherlands)

More on Physical activity

Exercise

downin rats1

1 study
  1. Exercise decreases amyloid-beta 40 in STZ-induced Alzheimer's disease model (Alz: 40.06 ± 6.17; Alz-Ex: 25.12 ± 2.92; p<0.001).

    “decreased liver concentration of Aβ40 (Alz: 40.06 ± 6.17; Alz-Ex: 25.12 ± 2.92; p<0.001) levels similar to non-exercising control animals”

    Animalsin STZ-induced Alzheimer's disease modelliver12 weeksmales

    Exercise Lowers Hepatic Amyloid β Concentrations in Alzheimer's Rodent Model

    Medicine and science in sports and exercise

More on Exercise

Slow-paced breathing

no changein humans1

1 study
  1. Slow-paced breathing showed no clear effect on amyloid-beta 40 in humans.

    “group differences were not significant for Aβ40 or Aβ42/Aβ40 ratios”

    Human trialplasma10 weeksn = 62

    Testing effects of paced breathing on plasma Aβ and brain perivascular spaces

    medRxiv : the preprint server for health sciencesPreprint

More on Slow-paced breathing

Ntbuha

downin human cells1

1 study
  1. Ntbuha decreases amyloid-beta 40 in iPSC-derived neurons harboring familial APP mutation.

    “Our preliminary data indicate that 2Mm of NtBuHa significantly reduces Aβ‐40 levels in the media of iNs compared to untreated iNs”

    Cellsin iPSC-derived neurons harboring familial APP mutation2 mM48 hours

    The role of lysosomal depalmitoylation in Alzheimer's Disease in vitro and in vivo models

    AAIC 2025 abstract

More on Ntbuha

Prolonged fasting

downin humans1

1 study
  1. Prolonged fasting decreases amyloid-beta 40 in humans.

    “Interestingly, PF significantly reduced plasma concentrations of both Aβ42 and Aβ40 ( E–G), suggesting either a decreased production rate or accelerated degradation of these amyloid peptides during fasting, with levels returning to baseline after refeeding.”

    Human trialwater-onlyaverage 9.8 ± 3.1-day water-only fast, followed by an average 5.3 ± 2.4 days of guided refeedingn = 20

    Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study

    Molecular metabolism

More on Prolonged fasting

Resveratrol

no changein humans1

1 study
  1. Resveratrol showed no clear effect on amyloid-beta 40 in mild to moderate Alzheimer disease (P > 0.05).

    “changes over the study period in the levels of Aβ40 in the blood and CSF of the patients treated with trans-resveratrol were not statistically significant (P > 0.05).”

    Human trialin mild to moderate Alzheimer diseaseoral500 mg once daily52 weeksn = 30

    Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial

    Neurology and therapy

More on Resveratrol

Kirtan kriya meditation

upin humans1

1 study
  1. Kirtan kriya meditation increases amyloid-beta 40 in humans (compared with music listening).

    “The KK group showed significantly greater increases in Aβ40 than the ML group.”

    Human trialcompared with music listeningplasma12 minutes/day12 weeksn = 53

    Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial

    Journal of Alzheimer's disease : JAD

More on Kirtan kriya meditation

Super-hard rice bread blended with black rice bran

downin mice1

1 study
  1. Super-hard rice bread blended with black rice bran decreases amyloid-beta 40 in mice (p < 0.01).

    “aged mice, which were fed a SRBBB diet for four weeks, showed lower amyloid β 40 peptide in the blood than mice fed a commercial diet (p < 0.01)”

    Animalsbloodfour weeks

    Effects of super-hard rice bread blended with black rice bran on amyloid β peptide production and abrupt increase in postprandial blood glucose levels in mice

    Bioscience, biotechnology, and biochemistry

More on Super-hard rice bread blended with black rice bran

Vitamin D

upin humans1

1 study
  1. Vitamin D increases amyloid-beta 40 in humans (vitamin D insufficient) (+14.9 ± 12.0 vs +12.8 ± 12.8 pg/mL, p = 0.045, effect size 0.228).

    “The vitamin group experienced greater plasma Aβ40 change than controls, +14.9 ± 12.0 and +12.8 ± 12.8 pg/mL (p = 0.045; effect size, 0.228).”

    Human trialvitamin D insufficientplasma50,000 IU/week8 weeks

    Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial

    Journal of Alzheimer's disease : JAD

More on Vitamin D

Effects

2

Gray matter volume

mediatesin humans1

1 study
  1. Amyloid-beta 40 is linked with gray matter volume in humans (association between enlarged ChP volume and reduced GMV) (proportion of mediation 10.73 %, 6.32 %, and 11.45 %).

    “plasma Aβ40 significantly mediated the association of enlarged ChP volume with the reduced GMV of insular region, hippocampus, and left thalamus in men”

    Humansassociation between enlarged ChP volume and reduced GMVmalesn = 814

    Enlarged choroid plexus is associated with reduced gray matter volumes and increased plasma amyloid-beta: a population-based study of older adults

    European journal of radiology

Cognitive function

downin humans1

1 study
  1. Amyloid-beta 40 is linked with worse cognitive function in Mexican Americans.

    “Aβ40 levels were negatively related to performance on Trails A, Trails B and Digit Symbol Substitution.”

    Humansin Mexican Americans

    The Relationship of Plasma Biomarkers of Alzheimer’s Disease and Neuropsychological Test Performance in Older Adults with Unimpaired Cognition: The Impact of Ethnicity

    Preprints.orgPreprint

Upstream

5

Black race

downin humans1

1 study
  1. Black race is linked with lower amyloid-beta 40 in humans (compared to White participants) (p = 0.004).

    “Black participants had lower plasma levels of Aβ40 (p = 0.004), Aβ42 (p = 0.002), and NfL (p = 0.022) compared to White participants.”

    Humanscompared to White participantsn = 269

    Generalizability of blood-based biomarkers of Alzheimer's disease and related dementias in a multicultural cohort of older adults: The effect of adjustment for kidney function

    Journal of Alzheimer's disease : JAD

ABCA7

upin mice1

1 study
  1. ABCA7 increases amyloid-beta 40 in LOAD2 mice.

    “older ABCA7 cohorts had elevated soluble and insoluble Aβ40 and Aβ42 in both plasma and brain samples.”

    Animalsin LOAD2 mice

    A1527G variant of ABCA7 increases soluble and insoluble Aβ40‐42 in an animal model for late‐onset Alzheimer's disease.

    AAIC 2025 abstract

More on ABCA7

FSHR

upin mice1

1 study
  1. FSHR increases amyloid-beta 40 in mice (3xTg background, shown by knockout, gene-dose-dependent).

    “There was also a gene-dose-dependent reduction mainly in the amyloid β40 isoform in whole brain extracts”

    Animals3xTg background, shown by knockout, gene-dose-dependentbrain

    Gene-dose-dependent reduction of Fshr expression improves spatial memory deficits in Alzheimer's mice

    Molecular psychiatry

More on FSHR

PAK1

no changein mice1

1 study
  1. PAK1 showed no clear effect on amyloid-beta 40 in heterozygous 3xTg-AD mice.

    “PAK inactivation had no effect on Aβ40 and Aβ42 levels”

    Animalsin heterozygous 3xTg-AD micefrontal cortex

    Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease

    Aging

More on PAK1

BACE1

no changein mice1

1 study
  1. BACE1 showed no clear effect on amyloid-beta 40 in Ts2 mice.

    “did not alter Aβ40 and Aβ42 peptide levels in brain”

    Animalsin Ts2 micebrain

    Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF

    Neurobiology of aging

More on BACE1

Associations

20

Sleep spindle duration and density

downin humans1

1 study
  1. Amyloid-beta 40 is associated with sleep spindle duration and density in humans (Cognitively unimpaired adults; particularly at frontal sites).

    “Higher Aβ42 and Aβ40 concentrations were associated with shorter duration and lower density of sleep spindles, particularly at frontal sites.”

    HumansCognitively unimpaired adults; particularly at frontal sitesplasmaovernightn = 40

    Associations Between Biomarkers of Alzheimer's Disease and Sleep in Cognitively Unimpaired Older Adults

    Annals of clinical and translational neurology

More on Sleep spindle duration and density

ECHDC3

mixedin humans1

1 study
  1. ECHDC3 is associated with amyloid-beta 40 in humans (missense/loss-of-function variants) (FDR q < 0.1).

    “Missense/LoF variants in 6 AD-associated genes (ECHDC3, CLU, APOE, EPHA1, ICA1L, CASS4) and 1 biomarker-associated gene (APOE) were associated with Ab40, Ab42/Ab40, pTau, and/or GFAP (FDR q < 0.1)”

    Humansmissense/loss-of-function variantsbloodn = 2,224

    Association between Alzheimer's disease-related genes and neurodegenerative blood-based biomarkers in Indian adults

    Frontiers in aging neuroscience

More on ECHDC3

Triglycerides in small VLDL

upin humans1

1 study
  1. Triglycerides in small VLDL is associated with amyloid-beta 40 in humans (β = 0.168, FDR = 4.362e-16).

    “Triglyceride-rich lipoproteins in small VLDL showed the strongest association with Aβ40 (β = 0.168, FDR = 4.362e-16).”

    Humansplasma

    Blood molecules linked to Alzheimer’s-related proteins

    Alzheimer's research & therapy

More on Triglycerides in small VLDL

Estimated glomerular filtration rate

upin humans1

1 study
  1. Estimated glomerular filtration rate is associated with amyloid-beta 40 in humans (every 1 ml/min per 1.73 m2 lower eGFR) (0.29 pg/ml higher A β 40 (95% CI, 0.01 to 0.56)).

    “0.29 pg/ml higher A β 40 (95% CI, 0.01 to 0.56)”

    Reviewevery 1 ml/min per 1.73 m2 lower eGFRblood

    Kidney Function and Blood and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Related Dementias: Systematic Review and Meta-Analysis

    Journal of the American Society of Nephrology : JASN

More on Estimated glomerular filtration rate

Congestive heart failure

upin humans1HR 2.04

1 study
  1. Amyloid-beta 40 is linked with a higher risk of congestive heart failure in humans (HR 2.04, 95% CI 1.03-4.02).

    “Higher plasma Aβ40 levels (per unit of the natural log of the protein level) were associated with an increased risk of HF (hazard ratio [HR] 95% confidence interval [CI], p): (2.04[1.03‐4.02], 0.040)”

    Humansplasma10 yearsn = 3,125

    Plasma Amyloid‐β Levels are Associated with Risk of Heart Failure: Framingham Heart Study

    AAIC 2025 abstract

More on Congestive heart failure

bFGF

upin humans1

1 study
  1. bFGF is associated with amyloid-beta 40 in humans (interaction with African ancestry) (β = 0.83, P = .03).

    “interaction between cardiovascular biomarker and degree of African ancestry was observed for bFGF (β = 0.83, P = .03) while predicting Aβ40”

    Humansinteraction with African ancestryn = 1,534

    Associations of blood‐based biomarkers of vascular function with biomarkers of Alzheimer's Disease in individuals of admixed ancestry

    AAIC 2025 abstract

More on bFGF

VEGF

upin humans1

1 study
  1. VEGF is associated with amyloid-beta 40 in humans.

    “Aβ40 is associated with VEGF, PlGF, VCAM‐1, HbA1c, and African ancestry”

    Humansn = 1,534

    Associations of blood‐based biomarkers of vascular function with biomarkers of Alzheimer's Disease in individuals of admixed ancestry

    AAIC 2025 abstract

More on VEGF

Social network scale

mixedin humans1

1 study
  1. social network scale is associated with amyloid-beta 40 in humans.

    “Notably, Aβ40 and GFAP were independently influenced by social network scale”

    Humansplasman = 1,026

    Influence of Age, Sex, Vascular and Lifestyle Factors on Alzheimer's Disease biomarkers among Indigenous Africans: Preliminary Findings from the VALIANT Cohort

    AAIC 2025 abstract

Letter fluency

downin humans1

1 study
  1. Amyloid-beta 40 predicts letter fluency in White-non-Hispanic older adults (b=-0.05, stb=-0.36, p=0.048).

    “higher Abeta40 (b=‐0.05, stb= ‐0.36, p = 0.048) and GFAP (b =‐0.03, stb=‐0.35, p = 0.024) concentrations predicted lower letter fluency scores”

    Humansin White-non-Hispanic older adults

    Associations between cognitive and clinical functioning and AD blood based biomarkers among Hispanic and WNH older adults

    AAIC 2025 abstract

Amyloid-beta 42

upin humans1

1 study
  1. Amyloid-beta 42 is associated with amyloid-beta 40 in humans (ρ = .52‐.88).

    “Aβ proteinopathy proteins showed moderate to strong correlations with each other (ρ = .52‐.88)”

    Humansplasman = 116

    Associations between classical Alzheimer’s Disease biomarkers and key proteins defining potential pathophysiological mechanisms – A multi‐analyte proteomic analysis

    AAIC 2025 abstract

More on Amyloid-beta 42

All 20

Latest

Dec 2025: 25Jan 2026: 21Feb 2026: 2Mar 2026: 8Apr 2026: 3May 2026: 4Jun 2026: 7Jul 2026: 2Aug 2026: 5Sep 2026: 5Oct 2026: 6Nov 2026: 391 papers in 12 months
bioRxiv

Aging linked to blood and brain changes in chimpanzees

A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.

Preprint: cross-sectional studyMechanisms
Nature Communications

Nitric oxide and vibration linked to more brain proteins in blood

In a trial of 29 healthy adults, the combined intervention was associated with changes in brain fluid movement alongside higher blood levels of brain-derived proteins.In a trial of 29 healthy adults, the combined intervention was associated with changes in brain fluid movement alongside higher blood levels of brain-derived proteins.

Randomized trial · 22 peopleWhole-body vibration
Neurology

Blood markers modestly predicted dementia in older adults

Over a median 12.2 years, the markers identified 41.7%–59.5% of people who received a dementia diagnosis.Over a median 12.2 years, the markers identified 41.7%–59.5% of people who received a dementia diagnosis.

Cohort · 5,225 peopleAll-cause dementia
medRxiv

Nerve-cell injury marker linked to death risk at ages 92–107

Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.

Preprint: cohort · 559 peopleBiomarkers
Sleep & Breathing

Blood markers linked to later cognitive problems in sleep apnea

Among 286 adults with sleep apnea, 68 developed cognitive impairment over a median 4.18 years; higher levels of two blood markers were linked to risk.Among 286 adults with sleep apnea, 68 developed cognitive impairment over a median 4.18 years; higher levels of two blood markers were linked to risk.

Cohort study of 286 peopleBiomarkers

See all 217 papers on amyloid-beta 40